$148,10
-$6,40(-4,14 %)
*Data last updated: 2026-05-08 17:22 (UTC+8)
As of 2026-05-08 17:22, Becton Dickinson & Co (BDX) is priced at $148,10, with a total market cap of $55,52B, a P/E ratio of 19,75, and a dividend yield of 2,43 %. Today, the stock price fluctuated between $146,49 and $158,85. The current price is 1,09 % above the day's low and 6,76 % below the day's high, with a trading volume of 5,13M. Over the past 52 weeks, BDX has traded between $142,00 to $158,85, and the current price is -6,76 % away from the 52-week high.
BDX Key Stats
Yesterday's Close$144,76
Market Cap$55,52B
Volumen5,13M
P/E Ratio19,75
Dividend Yield (TTM)2,43 %
Dividend Amount$1,05
Diluted EPS (TTM)4,05
Net Income (FY)$1,67B
Revenue (FY)$21,83B
Earnings Date2026-08-06
EPS Estimate3,09
Revenue Estimate$4,90B
Shares Outstanding383,56M
Beta (1Y)0.285
Ex-Dividend Date2026-06-09
Dividend Payment Date2026-06-30
About BDX
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication and infusion therapy delivery systems, medication compounding workflow systems, automated medication dispensing and supply management systems, and medication inventory optimization and tracking systems; syringes, pen needles, and other products for diabetes; and prefillable drug delivery systems. Its BD Life Sciences segment provides specimen and blood collection products; automated blood and tuberculosis culturing, molecular testing, microorganism identification and drug susceptibility, and liquid-based cytology systems, as well as rapid diagnostic assays, microbiology laboratory automation products, and plated media products; and fluorescence-activated cell sorters and analyzers, antibodies and kits, reagent systems, and solutions for single-cell gene expression analysis, as well as clinical oncology, immunological, and transplantation diagnostic/monitoring reagents and analyzers. The company's BD Interventional segment offers hernia and soft tissue repair, biological and bioresorbable grafts, biosurgery, and other surgical products; surgical infection prevention, surgical and laparoscopic instrumentation products; peripheral intervention products; and urology and critical care products. The company was founded in 1897 and is based in Franklin Lakes, New Jersey.
SectorHealthcare
IndustryMedical - Instruments & Supplies
CEOThomas E. Polen Jr.
HeadquartersFranklin Lakes,NJ,US
Official Websitehttps://www.bd.com
Employees (FY)72,00K
Average Revenue (1Y)$303,31K
Net Income per Employee$23,30K
Erfahren Sie mehr über Becton Dickinson & Co (BDX)
Gate Learn Articles
Beldex Coin Preisprognose für 2030 in indischen Rupien: Langfristiger WachstumsausblickMit Ausblick auf das Jahr 2030 sieht der Markt die Zukunft von Beldex weiterhin optimistisch. Es wird erwartet, dass BDX sich beständig weiterentwickelt und stetig wächst.2025-09-15

XRP Preisvorhersage: Analyse zukünftiger Trends und InvestitionsmöglichkeitenDieser Artikel wird sich mit der Preisvorhersage von Ripple XRP befassen, die möglichen Preisentwicklungen von XRP in der Zukunft analysieren und wertvolle Referenzen für Investoren bezüglich der XRP-Investition durch die Kombination von Markttrends, Trumps Politik und makroökonomischen Faktoren bereitstellen. Sowohl kurzfristige Händler als auch langfristige Investoren können nützliche Informationen daraus gewinnen.2025-03-17

Blogs
Warum könnte eine schrittweise Liquiditätsverbesserung zu einer strukturellen Neubewertung von BDX führen?Als Blockchain-Netzwerk, das sich auf Datenschutz-Infrastruktur und kettenübergreifende Interoperabilität fokussiert, strebt BDX seit Langem danach, die Liquidität an Börsen mit dem Ausbau seines Ökosystems in Einklang zu bringen.2026-03-03

BDX Token Kursprognose 2026: Kann diese aufstrebende Privacy Coin den Durchbruch schaffen? Eine umfassende AnalyseDatenschutz ist im digitalen Zeitalter zu einem immer wertvolleren Gut geworden, und das Beldex-Projekt widmet sich dem Aufbau einer Infrastruktur zu seinem Schutz.2026-01-28

Analyse der Preisprognose für den $BDX-Token im Jahr 2026: Kann Beldex den Durchbruch schaffen?Da sogenannte Privacy-Coins immer mehr Aufmerksamkeit erhalten, rückt auch Beldex (BDX) – ein Projekt, das sich dem Aufbau eines dezentralen Ökosystems für vertrauliche Anwendungen widmet – verstärkt in den Fokus von Investoren, die insbesondere die Kursentwicklung mit großem Interesse verfolgen.2026-01-27

Becton Dickinson & Co (BDX) FAQ
What's the stock price of Becton Dickinson & Co (BDX) today?
x
Becton Dickinson & Co (BDX) is currently trading at $148,10, with a 24h change of -4,14 %. The 52-week trading range is $142,00–$158,85.
What are the 52-week high and low prices for Becton Dickinson & Co (BDX)?
x
What is the price-to-earnings (P/E) ratio of Becton Dickinson & Co (BDX)? What does it indicate?
x
What is the market cap of Becton Dickinson & Co (BDX)?
x
What is the most recent quarterly earnings per share (EPS) for Becton Dickinson & Co (BDX)?
x
Should you buy or sell Becton Dickinson & Co (BDX) now?
x
What factors can affect the stock price of Becton Dickinson & Co (BDX)?
x
How to buy Becton Dickinson & Co (BDX) stock?
x
Risk Warning
The stock market involves a high level of risk and price volatility. The value of your investment may increase or decrease, and you may not recover the full amount invested. Past performance is not a reliable indicator of future results. Before making any investment decisions, you should carefully assess your investment experience, financial situation, investment objectives, and risk tolerance, and conduct your own research. Where appropriate, consult an independent financial adviser.
Disclaimer
The content on this page is provided for informational purposes only and does not constitute investment advice, financial advice, or trading recommendations. Gate shall not be held liable for any loss or damage resulting from such financial decisions. Further, take note that Gate may not be able to provide full service in certain markets and jurisdictions, including but not limited to the United States of America, Canada, Iran, and Cuba. For more information on Restricted Locations, please refer to the User Agreement.

















































































































































































































































































































































































